M Majewski Selected Research

M Majewski Research Topics

Disease

6	Neurogenic Urinary Bladder (Bladder, Neurogenic) 08/2016 - 01/2011
4	Rupture 01/2018 - 12/2002
3	Inflammation (Inflammations) 09/2017 - 01/2002
3	Ganglion Cysts (Ganglion) 08/2016 - 02/2001
3	Pain (Aches) 01/2012 - 09/2008
2	Ovarian Cysts (Ovarian Cyst) 09/2014 - 01/2004
1	Leukemia 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Cystitis 09/2017
1	Body Weight (Weight, Body) 09/2017
1	Abdominal Aortic Aneurysm 11/2015
1	Heart Failure 01/2015
1	Paralysis (Palsy) 10/2014
1	Cysts 09/2014
1	Hypersensitivity (Allergy) 01/2012
1	Multiple Sclerosis 07/2009
1	Endometritis 01/2009
1	Foreign Bodies (Foreign Body) 09/2008
1	Osteoarthritis 09/2008
1	Deglutition Disorders (Dysphagia) 09/2008
1	Pdgfra-Associated Chronic Eosinophilic Leukemia 11/2007
1	Hypertension (High Blood Pressure) 09/2007
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2007
1	Hip Osteoarthritis (Coxarthrosis) 10/2005
1	Infections 12/2002
1	Pathologic Processes 01/2002
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 03/2001
1	Genetic Translocation (Chromosomal Translocation) 03/2001
1	Lymphoma (Lymphomas) 03/2001
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 04/2000
1	Neoplasms (Cancer) 04/2000

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 05/2015 - 04/2000
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2012 - 02/2001
2	NeurotoxinsIBA 05/2015 - 07/2009
2	Proteins (Proteins, Gene)FDA Link 01/2009 - 03/2001
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2002 - 02/2001
2	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2002 - 02/2001
1	CollagenIBA 01/2018
1	Doxazosin (Cardura)FDA LinkGeneric 09/2017
1	resiniferatoxinIBA 08/2016
1	Hemoglobins (Hemoglobin)IBA 09/2015
1	CreatinineIBA 09/2015
1	TroponinIBA 09/2015
1	Botulinum Toxins (Botulinum Toxin)IBA 05/2015
1	dexamethasone 21-phosphate FDA LinkGeneric 09/2014
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2014
1	Cholinergic Agents (Cholinergics)IBA 09/2014
1	Calcitonin Gene-Related PeptideIBA 01/2012
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2012
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2012
1	conotoxin GVIBA 01/2012
1	CalbindinsIBA 01/2012
1	Substance PIBA 01/2012
1	VenomsIBA 01/2012
1	Phenobarbital (Luminal)FDA Link 01/2009
1	Messenger RNA (mRNA)IBA 01/2009
1	EnzymesIBA 01/2009
1	ProstaglandinsIBA 01/2009
1	PlasticsIBA 09/2008
1	InterferonsIBA 11/2007
1	Interferon-alpha (Interferon Alfa)IBA 11/2007
1	Serotonin (5 Hydroxytryptamine)IBA 09/2007
1	GastrinsIBA 09/2007
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2007
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2004
1	Peptides (Polypeptides)IBA 01/2002
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2002
1	GalaninIBA 01/2002
1	Tyrosine (L-Tyrosine)FDA Link 03/2001
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2001
1	Anaplastic Lymphoma KinaseIBA 03/2001
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2001
1	Phosphotransferases (Kinase)IBA 03/2001
1	PhosphoproteinsIBA 03/2001
1	NucleophosminIBA 03/2001
1	Choline O-Acetyltransferase (Choline Acetyltransferase)IBA 02/2001
1	MacrolidesIBA 04/2000
1	Immunosuppressive Agents (Immunosuppressants)IBA 04/2000

Therapy/Procedure

5	Investigational Therapies (Experimental Therapy) 05/2015 - 01/2011
3	Therapeutics 01/2012 - 01/2007
2	Hip Replacement Arthroplasty (Total Hip Replacement) 10/2014 - 10/2005
2	Conservative Treatment 07/2003 - 12/2002
1	Radiotherapy 01/2018
1	Drug Therapy (Chemotherapy) 08/2016
1	Stents 11/2015
1	Heart Transplantation (Grafting, Heart) 01/2015
1	Injections 01/2012
1	Osteotomy 09/2008
1	Aftercare (After-Treatment) 07/2003
1	Sutures (Suture) 07/2003
1	Axotomy 01/2002